As of 2026-09-30, the Relative Valuation of TG Therapeutics Inc (TGTX) is 52.54 USD. This relative valuation is based on P/E multiples. With the latest stock price at 56.19 USD, the upside of TG Therapeutics Inc based on Relative Valuation is -6.5%.
The range of the Relative Valuation is 28.52 - 82.77 USD.
| Range | Selected | |
| Trailing P/E multiples | 26.2x - 28.7x | 26.3x |
| Forward P/E multiples | 26.7x - 29.6x | 27.4x |
| Fair Price | 28.52 - 82.77 | 52.54 |
| Upside | -49.2% - 47.3% | -6.5% |
| Date | P/E |
| 2026-09-28 | 19.48 |
| 2026-09-25 | 19.91 |
| 2026-09-24 | 19.94 |
| 2026-09-23 | 19.42 |
| 2026-09-22 | 20.15 |
| 2026-09-21 | 19.82 |
| 2026-09-18 | 19.72 |
| 2026-09-17 | 19.58 |
| 2026-09-16 | 19.37 |
| 2026-09-15 | 18.39 |
| 2026-09-14 | 18.72 |
| 2026-09-11 | 18.69 |
| 2026-09-10 | 19.21 |
| 2026-09-09 | 18.95 |
| 2026-09-08 | 19.33 |
| 2026-09-04 | 19.41 |
| 2026-09-03 | 19.66 |
| 2026-09-02 | 19.73 |
| 2026-09-01 | 19.45 |
| 2026-08-31 | 18.83 |
| 2026-08-28 | 18.70 |
| 2026-08-27 | 19.32 |
| 2026-08-26 | 19.08 |
| 2026-08-25 | 19.22 |
| 2026-08-24 | 19.42 |
| 2026-08-21 | 18.82 |
| 2026-08-20 | 17.53 |
| 2026-08-19 | 17.92 |
| 2026-08-18 | 17.43 |
| 2026-08-17 | 17.09 |
| 2026-08-14 | 16.90 |
| 2026-08-13 | 16.62 |
| 2026-08-12 | 17.16 |
| 2026-08-11 | 17.30 |
| 2026-08-10 | 17.05 |
| 2026-08-07 | 17.25 |
| 2026-08-06 | 17.18 |
| 2026-08-05 | 17.30 |
| 2026-08-04 | 16.90 |
| 2026-08-03 | 16.01 |
| 2026-07-31 | 18.04 |
| 2026-07-30 | 18.56 |
| 2026-07-29 | 18.54 |
| 2026-07-28 | 19.03 |
| 2026-07-27 | 19.33 |
| 2026-07-24 | 19.43 |
| 2026-07-23 | 19.24 |
| 2026-07-22 | 18.27 |
| 2026-07-21 | 18.71 |
| 2026-07-20 | 18.71 |